HIV adenovector serotype Ad35 vaccine (GenVec/NIAID)

N/A

Report date: 2026/03/27 20:01:50

Base Information

Drug NameHIV adenovector serotype Ad35 vaccine (GenVec/NIAID)
Drug Alias NameVRC-rAd35 HIV vaccinerAd35-EnvA vaccineAd35HIV-EnvAVRC-HIVADV027-00-VP
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAcquired Immunodeficiency SyndromeHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesRwandaSouth Africa +[4] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenvec LlcNational Institute Of Allergy And Infectious Diseases (Niaid)
China Registration ClassN/A

Develop Information

Active CompaniesGenvec LlcNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsAcquired Immunodeficiency Syndrome

Other Information

ATC CodeN/A
Related LinksN/A